HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark D Erion Selected Research

Fructose-Bisphosphatase

1/2011Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
12/2007Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
7/2007Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark D Erion Research Topics

Disease

11Type 2 Diabetes Mellitus (MODY)
12/2016 - 05/2005
6Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 05/2005
5Hyperglycemia
01/2019 - 06/2006
3Insulin Resistance
01/2019 - 01/2011
3Hepatocellular Carcinoma (Hepatoma)
10/2009 - 02/2005
3Hepatitis B
02/2008 - 01/2005
2Metabolic Diseases (Metabolic Disease)
01/2019 - 12/2007
2Vomiting
01/2019 - 12/2005
2Weight Loss (Weight Reduction)
01/2019 - 01/2012
2Heart Diseases (Heart Disease)
01/2019 - 11/2016
2Cardiomegaly (Heart Hypertrophy)
01/2017 - 11/2016
2Neoplasms (Cancer)
10/2009 - 12/2006
2Infections
08/2007 - 01/2005
1Hyperinsulinism (Hyperinsulinemia)
01/2019
1Diabetes Mellitus
11/2018
1Dyslipidemias (Dyslipidemia)
01/2018
1Inflammation (Inflammations)
11/2016
1Cysts
11/2016
1Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
11/2016
1Weight Gain
01/2011
1Hyperlipidemias (Hyperlipidemia)
12/2010
1Non-alcoholic Fatty Liver Disease
02/2009
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2009
1Hypercholesterolemia
11/2008
1Body Weight (Weight, Body)
09/2007
1Hepatitis
02/2006
1Pain (Aches)
12/2005
1Ataxia (Dyssynergia)
12/2005
1Liver Diseases (Liver Disease)
02/2005
1Hepatitis C
02/2005
1Chronic Hepatitis B
11/2004
1Edema (Dropsy)
10/2003
1Ischemia
09/2003

Drug/Important Bio-Agent (IBA)

13Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2005
11ProdrugsIBA
12/2010 - 11/2004
6Insulin (Novolin)FDA Link
01/2022 - 01/2011
5Pharmaceutical PreparationsIBA
12/2010 - 05/2005
4GlycogenIBA
01/2019 - 06/2006
4Blood Glucose (Blood Sugar)IBA
11/2018 - 07/2007
4NucleosidesIBA
10/2009 - 10/2003
3Fructose-BisphosphataseIBA
01/2011 - 07/2007
3N,N'- ((5- (2- amino- 5- (2- methylpropyl)- 4- thiazolyl)- 2- furanyl)phosphinylidene)bis(alanine) diethyl esterIBA
01/2011 - 05/2005
32- ((3,5- dimethyl- 4- (4'- hydroxy- 3'- isopropylbenzyl)phenoxy)methyl)- 4- (3- chlorophenyl)- 2- oxido(1,3,2)dioxaphosphonaneIBA
02/2009 - 09/2007
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 01/2011
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019 - 01/2012
2EnzymesIBA
01/2011 - 12/2007
2Lactic Acid (Lactate)FDA LinkGeneric
01/2011 - 05/2005
2LipidsIBA
01/2011 - 11/2008
2adefovir dipivoxil (Hepsera)FDA Link
02/2008 - 11/2004
2Triglycerides (Triacylglycerol)IBA
09/2007 - 05/2005
2FructoseIBA
06/2006 - 05/2005
2Adenosine KinaseIBA
12/2005 - 10/2003
1Insulin ReceptorIBA
01/2022
1Appetite Depressants (Anorectics)IBA
01/2019
1LiraglutideFDA Link
01/2019
1CeramidesIBA
01/2019
1Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2019
1LeptinIBA
01/2019
1Glucagon-Like Peptide-1 ReceptorIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1MK-8722IBA
01/2017
1AMP-Activated Protein KinasesIBA
11/2016
1N- ((4- (1- (3- (3,5- dichlorophenyl)- 5- (6- methoxynaphthalen- 2- yl)- 1H- pyrazol- 1- yl)ethyl)phenyl)carbonyl)- beta- alanineIBA
11/2015
1Glucagon (Glukagon)FDA Link
11/2015
1Peptides (Polypeptides)IBA
01/2012
1Glucagon Receptors (Glucagon Receptor)IBA
01/2012
1Organophosphonates (Phosphonates)IBA
12/2010
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2009
1fludarabineIBA
10/2009
1triphosphoric acid (triphosphate)IBA
10/2009
14- amino- 1- (5- O- (2- oxo- 4- (4- pyridyl)- 1,3,2- dioxaphosphorinan- 2- yl)arabinofuranosyl)- 2(1H)- pyrimidinoneIBA
10/2009
1Nonesterified Fatty Acids (NEFA)IBA
02/2009
1Transaminases (Aminotransferases)IBA
02/2009
1Thyroid HormonesIBA
02/2009
1LDL CholesterolIBA
02/2009
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
02/2009
1pradefovirIBA
02/2008
1adefovirIBA
02/2008
1Adenosine Monophosphate (AMP)IBA
12/2007
1CholesterolIBA
09/2007
1KB 141IBA
09/2007
12'-C-methyladenosineIBA
08/2007
1NucleotidesIBA
02/2006
1BradykininIBA
12/2005
1pyrimidineIBA
12/2005
1Formaldehyde (Formol)FDA Link
12/2005
1Antiviral Agents (Antivirals)IBA
01/2005
1Lamivudine (Epivir)FDA Link
01/2005
1EsterasesIBA
11/2004
1Dihydrotachysterol (AT 10)IBA
10/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2003
1CarrageenanIBA
10/2003
1AutacoidsIBA
09/2003
1Adenosine (Adenocard)FDA LinkGeneric
09/2003

Therapy/Procedure

4Therapeutics
11/2018 - 11/2004
1Injections
01/2022
1Intraperitoneal Injections
12/2016
1Glycemic Control
12/2016
1Intravenous Administration
01/2010
1Aftercare (After-Treatment)
02/2009